EUVIMEDEUVIMED entdecken
Open Access

Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease

Frank Geurts iD, Layal Chaker iD, Anna C van der Burgh iD, Deirdre Cronin-Fenton iD, Robert A Fenton iD, Ewout J Hoorn iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.123.032835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Frank Geurts und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Erasmus Medical Center University Medical Center Rotterdam Rotterdam The Netherlands. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Kidney Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Inhibition of prostaglandin synthesis by nonsteroidal anti‐inflammatory drugs is associated with cardiovascular mortality and kidney disease. This study hypothesizes that urinary prostaglandin E2 (PGE2) and PGE2 metabolite (PGEM) excretions are markers of cardiovascular and kidney health, because they reflect both systemic and kidney‐derived PGE2 production. Methods and Results PGE2 and PGEM were measured in spot urine samples from 2291 participants (≥55 years old) of the population‐based Rotterdam Study. Urinary PGE2 and PGEM excretions were analyzed using linear regression analyses to identify cross‐sectional associations with cardiovascular risk factors and baseline estimated glomerular filtration rate (eGFR). Longitudinal associations with cardiovascular mortality and kidney outcomes (eGFR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesKidney DiseasesHumansMiddle AgedDinoprostoneCross-Sectional StudiesKidneyGlomerular Filtration RateAlbuminuriaRisk Factors

Stichwörter der Autor:innen

cardiovascular diseasechronic kidney diseaseprostaglandin E2

Substanzen

Dinoprostone

Autor:innen und Institutionen

  • Department of Internal Medicine, Erasmus Medical Center University Medical Center Rotterdam Rotterdam The Netherlands.
  • Department of Epidemiology, Erasmus Medical Center University Medical Center Rotterdam Rotterdam The Netherlands.
  • Department of Clinical Epidemiology, Department of Clinical Medicine Aarhus University Hospital and Aarhus University Aarhus Denmark.
  • Department of Biomedicine Aarhus University Aarhus Denmark.

ORCID-Profile: Frank Geurts, Layal Chaker, Anna C van der Burgh, Deirdre Cronin-Fenton, Robert A Fenton, Ewout J Hoorn

Zitieren

APA

Geurts, F., Chaker, L., van der Burgh, A. C., Cronin-Fenton, D., Fenton, R. A., & Hoorn, E. J. (2024). Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032835

Vancouver

Geurts F, Chaker L, van der Burgh AC, Cronin-Fenton D, Fenton RA, Hoorn EJ. Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.032835

BibTeX
@article{Geurts2024,
  author = {Geurts, Frank and Chaker, Layal and van der Burgh, Anna C and Cronin-Fenton, Deirdre and Fenton, Robert A and Hoorn, Ewout J},
  title = {Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.123.032835}
}
Kostenlos starten →